LOGSX Mutual Fund

LOGSX Mutual Fund

NAV$25.88
See how much of LOGSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$62M
Expense Ratio
1.04%
Dividend Yield (Current)
0.09%
Holdings
29
Inception Date
Jun 29, 2001
Fund Family
Oak Associates Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+8.79%
1 Year+22.36%
3 Year+12.20%
5 Year+7.32%
10 Year+8.05%

Asset Allocation

Stocks: 91.96%
Cash: 1.50%
Other: 6.54%
See how much of LOGSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
-Prime Solutions 3.25% 8/3/266.91%
CAHCardinal Health Inc.5.86%
JAZZJazz Pharmaceuticals Plc.5.77%
UTHRUnited Therapeutics Corp5.11%
EXELExelixis Inc4.95%
Top 10 Concentration: 51.80%Report Date: Jul 31, 2026
Download all 29 holdings for LOGSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.09%
Latest Distribution
$1.47
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

LOGSX Mutual Fund Overview

LOGSX Mutual Fund (Live Oak Health Sciences Fund) is managed by Oak Associates Funds with $62.1M in net assets. LOGSX expense ratio is 1.04%, holding 29 positions across sectors including Health Care, Financials. Inception date: 2001-06-29.

LOGSX performance shows a YTD return of 8.79%. The 1-year return is 22.36% and the 5-year return is 7.32%. LOGSX dividend yield stands at 0.09%.

LOGSX top holdings include Prime Solutions 3.25% 8/3/26 (6.9%), Cardinal Health Inc. (5.9%), Jazz Pharmaceuticals Plc. (5.8%), United Therapeutics Corp (5.1%), Exelixis Inc (5.0%). Go to all LOGSX holdings, LOGSX sectors, or LOGSX dividends.

LOGSX can be compared against other funds. Use LOGSX overlap to find shared positions, or LOGSX vs another fund for a side-by-side view. LOGSX alternatives are available via the screener, along with tax-loss harvesting opportunities.